Christopher Yea

Affiliations

  • Chief Development Officer at Kalvista Pharmaceuticals Inc. (KALV), 2024-02-22
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KALV $14.11 12,053 72,895 2024-02-20 Filing
KALV $15.01 39,886 66,160 2024-02-14 Filing
KALV $8.23 7,113 Officer 46,046 2023-11-20 Filing
KALV $10.73 7,142 Officer 41,662 2023-08-18 Filing
KALV $10.14 2,604 Officer 37,310 2023-05-18 Filing